Aviva Systems Biology Overview
- Year Founded
-
1997

- Status
-
Private
- Employees
-
30

- Latest Deal Type
-
2ndary - Private
- Investors
-
1
Aviva Systems Biology General Information
Description
Developer of antibodies intended to be used for research and diagnostic applications. The company's produced antibodies can adapt to the physical, chemical, and biological properties of cells to perform complex analysis in areas of transcription, epigenetics, and cell signaling, enabling researchers and scientists to study the transcription factors, cancer, cardiovascular, and cell biology for improved treatment methods.
Contact Information
Website
www.avivasysbio.comCorporate Office
- 10211 Pacific Mesa Boulevard
- Suite 401
- San Diego, CA 92121
- United States
Corporate Office
- 10211 Pacific Mesa Boulevard
- Suite 401
- San Diego, CA 92121
- United States
Aviva Systems Biology Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Secondary Transaction - Private | 01-Sep-2021 | Completed | Generating Revenue | |||
2. Later Stage VC | 25-Sep-2002 | Completed | Generating Revenue | |||
1. Early Stage VC | 12-Jun-2002 | $5M | $5M | Completed | Generating Revenue |
Aviva Systems Biology Comparisons
Industry
Financing
Details
Aviva Systems Biology Competitors (63)
One of Aviva Systems Biology’s 63 competitors is PeproTech, a Corporate Backed or Acquired company based in Cranbury, NJ.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
PeproTech | Corporate Backed or Acquired | Cranbury, NJ | ||||
BioLegend | Formerly Accelerator/Incubator backed | San Diego, CA | ||||
PlantForm | Venture Capital-Backed | Toronto, Canada | ||||
NexImmune | Formerly VC-backed | Gaithersburg, MD | ||||
ProMab Biotechnologies | Corporate Backed or Acquired | Richmond, CA |
Aviva Systems Biology Patents
Aviva Systems Biology Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3242929-A1 | Methods and devices for breaking cell aggregation and separating or enriching cells | Inactive | 09-Jan-2015 | ||
CA-2973388-A1 | Methods and devices for breaking cell aggregation and separating or enriching cells | Inactive | 09-Jan-2015 | ||
AU-2016205090-A1 | Methods and devices for breaking cell aggregation and separating or enriching cells | Inactive | 09-Jan-2015 | ||
US-20160237397-A1 | Methods and devices for breaking cell aggregation and separating or enriching cells | Inactive | 09-Jan-2015 | ||
EP-3242929-A4 | Methods and devices for breaking cell aggregation and separating or enriching cells | Inactive | 09-Jan-2015 | C12M47/04 |
Aviva Systems Biology Signals
Aviva Systems Biology Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Axon Instruments | Corporation | Minority |
Aviva Systems Biology Acquisitions (1)
Aviva Systems Biology’s most recent deal was a Merger/Acquisition with GenWay BioTech. The deal was made on 23-Feb-2017.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
GenWay BioTech | 23-Feb-2017 | Merger/Acquisition | Discovery Tools (Healthcare) |
Aviva Systems Biology FAQs
-
When was Aviva Systems Biology founded?
Aviva Systems Biology was founded in 1997.
-
Where is Aviva Systems Biology headquartered?
Aviva Systems Biology is headquartered in San Diego, CA.
-
What is the size of Aviva Systems Biology?
Aviva Systems Biology has 30 total employees.
-
What industry is Aviva Systems Biology in?
Aviva Systems Biology’s primary industry is Biotechnology.
-
Is Aviva Systems Biology a private or public company?
Aviva Systems Biology is a Private company.
-
What is Aviva Systems Biology’s current revenue?
The current revenue for Aviva Systems Biology is
. -
How much funding has Aviva Systems Biology raised over time?
Aviva Systems Biology has raised $16.8M.
-
Who are Aviva Systems Biology’s investors?
Axon Instruments has invested in Aviva Systems Biology.
-
Who are Aviva Systems Biology’s competitors?
PeproTech, BioLegend, PlantForm, NexImmune, and ProMab Biotechnologies are some of the 63 competitors of Aviva Systems Biology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »